instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the outcome of reaction 'Rhabdomyolysis'? | Breaking Therapeutic Inertia With Alirocumab in an 80-Year-Old Patient With Severe Hypercholesterolemia: A Case Report.
Background: Therapeutic inertia, defined as the failure to initiate or intensify therapy in a timely manner as per evidence-based clinical guidelines, is an important barrier limiting optimal care in ... | Recovered | ReactionOutcome | CC BY | 34307425 | 20,063,489 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Brain herniation'. | Efficacy of Solitaire AB stent-release angioplasty in acute middle cerebral artery atherosclerosis obliterative cerebral infarction.
BACKGROUND
In both national and international studies, the safety and effectiveness of treatment with the Solitaire stent in patients with ischemic stroke caused by acute large vessel occ... | ASPIRIN, CLOPIDOGREL BISULFATE, LIDOCAINE, TIROFIBAN | DrugsGivenReaction | CC BY-NC | 34307553 | 19,897,723 | 2021-07-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebral haemorrhage'. | Efficacy of Solitaire AB stent-release angioplasty in acute middle cerebral artery atherosclerosis obliterative cerebral infarction.
BACKGROUND
In both national and international studies, the safety and effectiveness of treatment with the Solitaire stent in patients with ischemic stroke caused by acute large vessel occ... | ASPIRIN, CLOPIDOGREL BISULFATE, LIDOCAINE, TIROFIBAN | DrugsGivenReaction | CC BY-NC | 34307553 | 19,897,723 | 2021-07-06 |
What was the administration route of drug 'TIROFIBAN'? | Efficacy of Solitaire AB stent-release angioplasty in acute middle cerebral artery atherosclerosis obliterative cerebral infarction.
BACKGROUND
In both national and international studies, the safety and effectiveness of treatment with the Solitaire stent in patients with ischemic stroke caused by acute large vessel occ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34307553 | 19,897,723 | 2021-07-06 |
What was the dosage of drug 'ASPIRIN'? | Efficacy of Solitaire AB stent-release angioplasty in acute middle cerebral artery atherosclerosis obliterative cerebral infarction.
BACKGROUND
In both national and international studies, the safety and effectiveness of treatment with the Solitaire stent in patients with ischemic stroke caused by acute large vessel occ... | 100 MG, QD | DrugDosageText | CC BY-NC | 34307553 | 19,897,723 | 2021-07-06 |
What was the dosage of drug 'CLOPIDOGREL BISULFATE'? | Efficacy of Solitaire AB stent-release angioplasty in acute middle cerebral artery atherosclerosis obliterative cerebral infarction.
BACKGROUND
In both national and international studies, the safety and effectiveness of treatment with the Solitaire stent in patients with ischemic stroke caused by acute large vessel occ... | 75 MG, QD | DrugDosageText | CC BY-NC | 34307553 | 19,897,723 | 2021-07-06 |
What was the outcome of reaction 'Brain herniation'? | Efficacy of Solitaire AB stent-release angioplasty in acute middle cerebral artery atherosclerosis obliterative cerebral infarction.
BACKGROUND
In both national and international studies, the safety and effectiveness of treatment with the Solitaire stent in patients with ischemic stroke caused by acute large vessel occ... | Fatal | ReactionOutcome | CC BY-NC | 34307553 | 19,897,723 | 2021-07-06 |
What was the outcome of reaction 'Cerebral haemorrhage'? | Efficacy of Solitaire AB stent-release angioplasty in acute middle cerebral artery atherosclerosis obliterative cerebral infarction.
BACKGROUND
In both national and international studies, the safety and effectiveness of treatment with the Solitaire stent in patients with ischemic stroke caused by acute large vessel occ... | Fatal | ReactionOutcome | CC BY-NC | 34307553 | 19,897,723 | 2021-07-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report.
BACKGROUND
Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B ... | ENTECAVIR | DrugsGivenReaction | CC BY-NC | 34307577 | 19,651,066 | 2021-07-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report.
BACKGROUND
Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B ... | ENTECAVIR | DrugsGivenReaction | CC BY-NC | 34307577 | 19,651,066 | 2021-07-06 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis B'. | COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report.
BACKGROUND
Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B ... | ENTECAVIR | DrugsGivenReaction | CC BY-NC | 34307577 | 19,651,066 | 2021-07-06 |
What is the weight of the patient? | COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report.
BACKGROUND
Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B ... | 63 kg. | Weight | CC BY-NC | 34307577 | 17,445,071 | 2021-07-06 |
What was the administration route of drug 'BICYCLOL'? | COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report.
BACKGROUND
Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B ... | Oral | DrugAdministrationRoute | CC BY-NC | 34307577 | 17,445,071 | 2021-07-06 |
What was the administration route of drug 'LACTOBACILLUS ACIDOPHILUS'? | COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report.
BACKGROUND
Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B ... | Oral | DrugAdministrationRoute | CC BY-NC | 34307577 | 17,445,071 | 2021-07-06 |
What was the administration route of drug 'LOPINAVIR\RITONAVIR'? | COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report.
BACKGROUND
Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B ... | Oral | DrugAdministrationRoute | CC BY-NC | 34307577 | 17,445,071 | 2021-07-06 |
What was the administration route of drug 'SODIUM CHLORIDE'? | COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report.
BACKGROUND
Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34307577 | 17,445,071 | 2021-07-06 |
What was the administration route of drug 'TRIMEBUTINE MALEATE'? | COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report.
BACKGROUND
Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B ... | Oral | DrugAdministrationRoute | CC BY-NC | 34307577 | 17,445,071 | 2021-07-06 |
What was the dosage of drug 'LOPINAVIR\RITONAVIR'? | COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report.
BACKGROUND
Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B ... | 200/50 | DrugDosageText | CC BY-NC | 34307577 | 17,445,071 | 2021-07-06 |
What was the outcome of reaction 'COVID-19'? | COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report.
BACKGROUND
Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B ... | Recovered | ReactionOutcome | CC BY-NC | 34307577 | 19,651,066 | 2021-07-06 |
What was the outcome of reaction 'Disease recurrence'? | COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report.
BACKGROUND
Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B ... | Recovered | ReactionOutcome | CC BY-NC | 34307577 | 19,651,066 | 2021-07-06 |
What was the outcome of reaction 'Hepatitis B reactivation'? | COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report.
BACKGROUND
Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B ... | Recovered | ReactionOutcome | CC BY-NC | 34307577 | 19,600,544 | 2021-07-06 |
What was the outcome of reaction 'Hepatitis B'? | COVID-19 or treatment associated immunosuppression may trigger hepatitis B virus reactivation: A case report.
BACKGROUND
Since the initial recognition of coronavirus disease 2019 (COVID-19) in Wuhan, this infectious disease has spread to most areas of the world. The pathogenesis of COVID-19 is yet unclear. Hepatitis B ... | Recovered | ReactionOutcome | CC BY-NC | 34307577 | 19,651,066 | 2021-07-06 |
What was the dosage of drug 'DOBUTAMINE HYDROCHLORIDE'? | Temporary coronary sinus pacing to improve ventricular dyssynchrony with cardiogenic shock: A case report.
BACKGROUND
Temporary transvenous pacing through the coronary sinus is a novel approach rarely used in treating unstable bradycardia. This modality could provide cardiac pacing while achieving better ventricular sy... | UNK; 7.5 G/KG/MIN | DrugDosageText | CC BY-NC | 34307610 | 19,962,896 | 2021-07-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abortion spontaneous'. | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | AZITHROMYCIN, CEFTRIAXONE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC | 34307626 | 19,935,875 | 2021-07-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Amniotic cavity infection'. | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | AZITHROMYCIN, CEFTRIAXONE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC | 34307626 | 19,935,875 | 2021-07-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | AZITHROMYCIN, CEFEPIME HYDROCHLORIDE, CEFTRIAXONE, CLARITHROMYCIN | DrugsGivenReaction | CC BY-NC | 34307626 | 20,022,013 | 2021-07-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gallbladder polyp'. | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | AZITHROMYCIN, CEFTRIAXONE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC | 34307626 | 19,935,875 | 2021-07-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Placental infarction'. | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | AZITHROMYCIN, CEFTRIAXONE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC | 34307626 | 19,935,875 | 2021-07-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | AZITHROMYCIN, CEFTRIAXONE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC | 34307626 | 19,935,875 | 2021-07-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Serratia bacteraemia'. | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | AZITHROMYCIN, CEFTRIAXONE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC | 34307626 | 19,935,875 | 2021-07-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Stillbirth'. | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | AZITHROMYCIN, CEFEPIME HYDROCHLORIDE, CEFTRIAXONE, CLARITHROMYCIN, MEROPENEM | DrugsGivenReaction | CC BY-NC | 34307626 | 19,998,038 | 2021-07-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vaginal haemorrhage'. | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | AZITHROMYCIN, CEFTRIAXONE, UNSPECIFIED INGREDIENT | DrugsGivenReaction | CC BY-NC | 34307626 | 19,935,875 | 2021-07-16 |
What was the administration route of drug 'AZITHROMYCIN'? | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | Oral | DrugAdministrationRoute | CC BY-NC | 34307626 | 19,998,038 | 2021-07-16 |
What was the administration route of drug 'CEFEPIME HYDROCHLORIDE'? | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34307626 | 19,998,038 | 2021-07-16 |
What was the administration route of drug 'CEFTRIAXONE'? | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 34307626 | 19,998,038 | 2021-07-16 |
What was the administration route of drug 'UNSPECIFIED INGREDIENT'? | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | Cutaneous | DrugAdministrationRoute | CC BY-NC | 34307626 | 19,935,875 | 2021-07-16 |
What was the dosage of drug 'UNSPECIFIED INGREDIENT'? | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | INTERMITTENTLY | DrugDosageText | CC BY-NC | 34307626 | 19,935,875 | 2021-07-16 |
What was the outcome of reaction 'Abortion spontaneous'? | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | Recovered | ReactionOutcome | CC BY-NC | 34307626 | 19,935,875 | 2021-07-16 |
What was the outcome of reaction 'Maternal exposure during pregnancy'? | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | Recovered | ReactionOutcome | CC BY-NC | 34307626 | 19,935,875 | 2021-07-16 |
What was the outcome of reaction 'Preterm premature rupture of membranes'? | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | Recovered | ReactionOutcome | CC BY-NC | 34307626 | 19,935,875 | 2021-07-16 |
What was the outcome of reaction 'Pyrexia'? | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | Recovered | ReactionOutcome | CC BY-NC | 34307626 | 19,935,875 | 2021-07-16 |
What was the outcome of reaction 'Serratia bacteraemia'? | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | Recovering | ReactionOutcome | CC BY-NC | 34307626 | 19,935,875 | 2021-07-16 |
What was the outcome of reaction 'Vaginal haemorrhage'? | Chorioamnionitis caused by Serratia marcescens in a healthcare worker: A case report.
BACKGROUND
Healthcare workers (HCWs) are at an increased risk for exposure to infections. Serratia marcescens (S. marcescens) is a gram-negative, opportunistic and nosocomial pathogen belonging to the Enterobacterieae family. A few ca... | Recovered | ReactionOutcome | CC BY-NC | 34307626 | 19,935,875 | 2021-07-16 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Tofacitinib-Associated Cerebral Venous Sinus Thrombosis.
Tofacitinib is a Janus kinase inhibitor indicated to treat adult patients with moderately to severely active ulcerative colitis (UC). Although thrombosis is a known adverse event of tofacitinib, there are no reports specific to cerebral venous sinus thrombosis (C... | ADALIMUMAB, BUDESONIDE, MESALAMINE | DrugsGivenReaction | CC BY-NC-ND | 34307712 | 20,950,373 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Tofacitinib-Associated Cerebral Venous Sinus Thrombosis.
Tofacitinib is a Janus kinase inhibitor indicated to treat adult patients with moderately to severely active ulcerative colitis (UC). Although thrombosis is a known adverse event of tofacitinib, there are no reports specific to cerebral venous sinus thrombosis (C... | ADALIMUMAB, BUDESONIDE, MESALAMINE | DrugsGivenReaction | CC BY-NC-ND | 34307712 | 20,950,373 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | Tofacitinib-Associated Cerebral Venous Sinus Thrombosis.
Tofacitinib is a Janus kinase inhibitor indicated to treat adult patients with moderately to severely active ulcerative colitis (UC). Although thrombosis is a known adverse event of tofacitinib, there are no reports specific to cerebral venous sinus thrombosis (C... | ADALIMUMAB, BUDESONIDE, MESALAMINE | DrugsGivenReaction | CC BY-NC-ND | 34307712 | 20,923,606 | 2021-07 |
What was the administration route of drug 'BUDESONIDE'? | Tofacitinib-Associated Cerebral Venous Sinus Thrombosis.
Tofacitinib is a Janus kinase inhibitor indicated to treat adult patients with moderately to severely active ulcerative colitis (UC). Although thrombosis is a known adverse event of tofacitinib, there are no reports specific to cerebral venous sinus thrombosis (C... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 34307712 | 20,923,606 | 2021-07 |
What was the dosage of drug 'TOFACITINIB CITRATE'? | Tofacitinib-Associated Cerebral Venous Sinus Thrombosis.
Tofacitinib is a Janus kinase inhibitor indicated to treat adult patients with moderately to severely active ulcerative colitis (UC). Although thrombosis is a known adverse event of tofacitinib, there are no reports specific to cerebral venous sinus thrombosis (C... | 10 mg (milligrams). | DrugDosage | CC BY-NC-ND | 34307712 | 20,892,683 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Accidental underdose'. | Mantle Cell Lymphoma Presenting as Diarrhea in a Liver Transplant Recipient.
We present a 63-year-old man with a medical history of hepatocellular carcinoma who underwent orthotopic liver transplant 10 years prior on long-term immunosuppressive therapy. The patient presented to the clinic with diarrhea, and the workup ... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, URSODIOL | DrugsGivenReaction | CC BY | 34307713 | 20,934,068 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | Mantle Cell Lymphoma Presenting as Diarrhea in a Liver Transplant Recipient.
We present a 63-year-old man with a medical history of hepatocellular carcinoma who underwent orthotopic liver transplant 10 years prior on long-term immunosuppressive therapy. The patient presented to the clinic with diarrhea, and the workup ... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, URSODIOL | DrugsGivenReaction | CC BY | 34307713 | 20,950,060 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Incorrect dosage administered'. | Mantle Cell Lymphoma Presenting as Diarrhea in a Liver Transplant Recipient.
We present a 63-year-old man with a medical history of hepatocellular carcinoma who underwent orthotopic liver transplant 10 years prior on long-term immunosuppressive therapy. The patient presented to the clinic with diarrhea, and the workup ... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, URSODIOL | DrugsGivenReaction | CC BY | 34307713 | 20,942,729 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Incorrect dose administered'. | Mantle Cell Lymphoma Presenting as Diarrhea in a Liver Transplant Recipient.
We present a 63-year-old man with a medical history of hepatocellular carcinoma who underwent orthotopic liver transplant 10 years prior on long-term immunosuppressive therapy. The patient presented to the clinic with diarrhea, and the workup ... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, URSODIOL | DrugsGivenReaction | CC BY | 34307713 | 20,950,060 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mantle cell lymphoma'. | Mantle Cell Lymphoma Presenting as Diarrhea in a Liver Transplant Recipient.
We present a 63-year-old man with a medical history of hepatocellular carcinoma who underwent orthotopic liver transplant 10 years prior on long-term immunosuppressive therapy. The patient presented to the clinic with diarrhea, and the workup ... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, URSODIOL | DrugsGivenReaction | CC BY | 34307713 | 20,934,068 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Mantle Cell Lymphoma Presenting as Diarrhea in a Liver Transplant Recipient.
We present a 63-year-old man with a medical history of hepatocellular carcinoma who underwent orthotopic liver transplant 10 years prior on long-term immunosuppressive therapy. The patient presented to the clinic with diarrhea, and the workup ... | CYCLOSPORINE, MYCOPHENOLATE MOFETIL, URSODIOL | DrugsGivenReaction | CC BY | 34307713 | 20,934,068 | 2021-07 |
What was the outcome of reaction 'Incorrect dosage administered'? | Mantle Cell Lymphoma Presenting as Diarrhea in a Liver Transplant Recipient.
We present a 63-year-old man with a medical history of hepatocellular carcinoma who underwent orthotopic liver transplant 10 years prior on long-term immunosuppressive therapy. The patient presented to the clinic with diarrhea, and the workup ... | Recovering | ReactionOutcome | CC BY | 34307713 | 20,938,240 | 2021-07 |
What was the outcome of reaction 'Mantle cell lymphoma'? | Mantle Cell Lymphoma Presenting as Diarrhea in a Liver Transplant Recipient.
We present a 63-year-old man with a medical history of hepatocellular carcinoma who underwent orthotopic liver transplant 10 years prior on long-term immunosuppressive therapy. The patient presented to the clinic with diarrhea, and the workup ... | Recovering | ReactionOutcome | CC BY | 34307713 | 20,934,068 | 2021-07 |
What was the outcome of reaction 'Product communication issue'? | Mantle Cell Lymphoma Presenting as Diarrhea in a Liver Transplant Recipient.
We present a 63-year-old man with a medical history of hepatocellular carcinoma who underwent orthotopic liver transplant 10 years prior on long-term immunosuppressive therapy. The patient presented to the clinic with diarrhea, and the workup ... | Recovering | ReactionOutcome | CC BY | 34307713 | 20,938,240 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | An Unusual Cause of Large Bowel Obstruction in a Patient With Ulcerative Colitis.
Endometriosis is a rare cause of large bowel obstruction and has been infrequently reported in patients with inflammatory bowel disease. We present an unusual case of a young woman with ulcerative colitis, who presented with a large bowel... | LEUPROLIDE ACETATE | DrugsGivenReaction | CC BY-NC-ND | 34307716 | 20,890,841 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug effective for unapproved indication'. | An Unusual Cause of Large Bowel Obstruction in a Patient With Ulcerative Colitis.
Endometriosis is a rare cause of large bowel obstruction and has been infrequently reported in patients with inflammatory bowel disease. We present an unusual case of a young woman with ulcerative colitis, who presented with a large bowel... | LEUPROLIDE ACETATE | DrugsGivenReaction | CC BY-NC-ND | 34307716 | 20,890,841 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | An Unusual Cause of Large Bowel Obstruction in a Patient With Ulcerative Colitis.
Endometriosis is a rare cause of large bowel obstruction and has been infrequently reported in patients with inflammatory bowel disease. We present an unusual case of a young woman with ulcerative colitis, who presented with a large bowel... | LEUPROLIDE ACETATE | DrugsGivenReaction | CC BY-NC-ND | 34307716 | 20,890,841 | 2021-07 |
What was the administration route of drug 'LEUPROLIDE ACETATE'? | An Unusual Cause of Large Bowel Obstruction in a Patient With Ulcerative Colitis.
Endometriosis is a rare cause of large bowel obstruction and has been infrequently reported in patients with inflammatory bowel disease. We present an unusual case of a young woman with ulcerative colitis, who presented with a large bowel... | Intramuscular | DrugAdministrationRoute | CC BY-NC-ND | 34307716 | 20,890,841 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | Acute Hyponatremia After a Religious Fast.
Our objective is to describe how polydipsia and intake of nonsteroidal anti-inflammatory drugs (NSAIDs) after fasting while breastfeeding may result in acute symptomatic hyponatremia.
We present the case of a 24-year-old woman at 4 weeks postpartum who engaged in a 20-hour fas... | IBUPROFEN | DrugsGivenReaction | CC BY-NC-ND | 34307843 | 19,720,589 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Headache'. | Acute Hyponatremia After a Religious Fast.
Our objective is to describe how polydipsia and intake of nonsteroidal anti-inflammatory drugs (NSAIDs) after fasting while breastfeeding may result in acute symptomatic hyponatremia.
We present the case of a 24-year-old woman at 4 weeks postpartum who engaged in a 20-hour fas... | IBUPROFEN | DrugsGivenReaction | CC BY-NC-ND | 34307843 | 19,720,589 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyponatraemia'. | Acute Hyponatremia After a Religious Fast.
Our objective is to describe how polydipsia and intake of nonsteroidal anti-inflammatory drugs (NSAIDs) after fasting while breastfeeding may result in acute symptomatic hyponatremia.
We present the case of a 24-year-old woman at 4 weeks postpartum who engaged in a 20-hour fas... | IBUPROFEN | DrugsGivenReaction | CC BY-NC-ND | 34307843 | 19,720,589 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypovolaemia'. | Acute Hyponatremia After a Religious Fast.
Our objective is to describe how polydipsia and intake of nonsteroidal anti-inflammatory drugs (NSAIDs) after fasting while breastfeeding may result in acute symptomatic hyponatremia.
We present the case of a 24-year-old woman at 4 weeks postpartum who engaged in a 20-hour fas... | IBUPROFEN | DrugsGivenReaction | CC BY-NC-ND | 34307843 | 19,720,589 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during breast feeding'. | Acute Hyponatremia After a Religious Fast.
Our objective is to describe how polydipsia and intake of nonsteroidal anti-inflammatory drugs (NSAIDs) after fasting while breastfeeding may result in acute symptomatic hyponatremia.
We present the case of a 24-year-old woman at 4 weeks postpartum who engaged in a 20-hour fas... | IBUPROFEN | DrugsGivenReaction | CC BY-NC-ND | 34307843 | 19,720,589 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nausea'. | Acute Hyponatremia After a Religious Fast.
Our objective is to describe how polydipsia and intake of nonsteroidal anti-inflammatory drugs (NSAIDs) after fasting while breastfeeding may result in acute symptomatic hyponatremia.
We present the case of a 24-year-old woman at 4 weeks postpartum who engaged in a 20-hour fas... | IBUPROFEN | DrugsGivenReaction | CC BY-NC-ND | 34307843 | 19,720,589 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urinary retention'. | Acute Hyponatremia After a Religious Fast.
Our objective is to describe how polydipsia and intake of nonsteroidal anti-inflammatory drugs (NSAIDs) after fasting while breastfeeding may result in acute symptomatic hyponatremia.
We present the case of a 24-year-old woman at 4 weeks postpartum who engaged in a 20-hour fas... | IBUPROFEN | DrugsGivenReaction | CC BY-NC-ND | 34307843 | 19,720,589 | 2021 |
What is the weight of the patient? | Acute Hyponatremia After a Religious Fast.
Our objective is to describe how polydipsia and intake of nonsteroidal anti-inflammatory drugs (NSAIDs) after fasting while breastfeeding may result in acute symptomatic hyponatremia.
We present the case of a 24-year-old woman at 4 weeks postpartum who engaged in a 20-hour fas... | 58 kg. | Weight | CC BY-NC-ND | 34307843 | 19,720,589 | 2021 |
What was the outcome of reaction 'Asthenia'? | Acute Hyponatremia After a Religious Fast.
Our objective is to describe how polydipsia and intake of nonsteroidal anti-inflammatory drugs (NSAIDs) after fasting while breastfeeding may result in acute symptomatic hyponatremia.
We present the case of a 24-year-old woman at 4 weeks postpartum who engaged in a 20-hour fas... | Recovered | ReactionOutcome | CC BY-NC-ND | 34307843 | 19,720,589 | 2021 |
What was the outcome of reaction 'Headache'? | Acute Hyponatremia After a Religious Fast.
Our objective is to describe how polydipsia and intake of nonsteroidal anti-inflammatory drugs (NSAIDs) after fasting while breastfeeding may result in acute symptomatic hyponatremia.
We present the case of a 24-year-old woman at 4 weeks postpartum who engaged in a 20-hour fas... | Recovered | ReactionOutcome | CC BY-NC-ND | 34307843 | 19,720,589 | 2021 |
What was the outcome of reaction 'Hyponatraemia'? | Acute Hyponatremia After a Religious Fast.
Our objective is to describe how polydipsia and intake of nonsteroidal anti-inflammatory drugs (NSAIDs) after fasting while breastfeeding may result in acute symptomatic hyponatremia.
We present the case of a 24-year-old woman at 4 weeks postpartum who engaged in a 20-hour fas... | Recovered | ReactionOutcome | CC BY-NC-ND | 34307843 | 19,720,589 | 2021 |
What was the outcome of reaction 'Hypovolaemia'? | Acute Hyponatremia After a Religious Fast.
Our objective is to describe how polydipsia and intake of nonsteroidal anti-inflammatory drugs (NSAIDs) after fasting while breastfeeding may result in acute symptomatic hyponatremia.
We present the case of a 24-year-old woman at 4 weeks postpartum who engaged in a 20-hour fas... | Recovered | ReactionOutcome | CC BY-NC-ND | 34307843 | 19,720,589 | 2021 |
What was the outcome of reaction 'Nausea'? | Acute Hyponatremia After a Religious Fast.
Our objective is to describe how polydipsia and intake of nonsteroidal anti-inflammatory drugs (NSAIDs) after fasting while breastfeeding may result in acute symptomatic hyponatremia.
We present the case of a 24-year-old woman at 4 weeks postpartum who engaged in a 20-hour fas... | Recovered | ReactionOutcome | CC BY-NC-ND | 34307843 | 19,720,589 | 2021 |
What was the outcome of reaction 'Urinary retention'? | Acute Hyponatremia After a Religious Fast.
Our objective is to describe how polydipsia and intake of nonsteroidal anti-inflammatory drugs (NSAIDs) after fasting while breastfeeding may result in acute symptomatic hyponatremia.
We present the case of a 24-year-old woman at 4 weeks postpartum who engaged in a 20-hour fas... | Recovered | ReactionOutcome | CC BY-NC-ND | 34307843 | 19,720,589 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthralgia'. | Methimazole Desensitization in a 4-Year-Old With Refractory Graves Disease.
To describe a 4-year-old girl with Graves disease and methimazole allergy who underwent desensitization, allowing continued methimazole use when other treatments were contraindicated.
We formulated a desensitization plan utilizing cetirizine an... | CETIRIZINE HYDROCHLORIDE, METHIMAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34307852 | 18,356,928 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug hypersensitivity'. | Methimazole Desensitization in a 4-Year-Old With Refractory Graves Disease.
To describe a 4-year-old girl with Graves disease and methimazole allergy who underwent desensitization, allowing continued methimazole use when other treatments were contraindicated.
We formulated a desensitization plan utilizing cetirizine an... | CETIRIZINE HYDROCHLORIDE, METHIMAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34307852 | 18,356,928 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myalgia'. | Methimazole Desensitization in a 4-Year-Old With Refractory Graves Disease.
To describe a 4-year-old girl with Graves disease and methimazole allergy who underwent desensitization, allowing continued methimazole use when other treatments were contraindicated.
We formulated a desensitization plan utilizing cetirizine an... | CETIRIZINE HYDROCHLORIDE, METHIMAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34307852 | 18,356,928 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Urticaria'. | Methimazole Desensitization in a 4-Year-Old With Refractory Graves Disease.
To describe a 4-year-old girl with Graves disease and methimazole allergy who underwent desensitization, allowing continued methimazole use when other treatments were contraindicated.
We formulated a desensitization plan utilizing cetirizine an... | CETIRIZINE HYDROCHLORIDE, METHIMAZOLE | DrugsGivenReaction | CC BY-NC-ND | 34307852 | 18,356,928 | 2021 |
What was the dosage of drug 'CETIRIZINE HYDROCHLORIDE'? | Methimazole Desensitization in a 4-Year-Old With Refractory Graves Disease.
To describe a 4-year-old girl with Graves disease and methimazole allergy who underwent desensitization, allowing continued methimazole use when other treatments were contraindicated.
We formulated a desensitization plan utilizing cetirizine an... | 5 MILLIGRAM/KILOGRAM, QD | DrugDosageText | CC BY-NC-ND | 34307852 | 18,356,928 | 2021 |
What was the outcome of reaction 'Arthralgia'? | Methimazole Desensitization in a 4-Year-Old With Refractory Graves Disease.
To describe a 4-year-old girl with Graves disease and methimazole allergy who underwent desensitization, allowing continued methimazole use when other treatments were contraindicated.
We formulated a desensitization plan utilizing cetirizine an... | Recovered | ReactionOutcome | CC BY-NC-ND | 34307852 | 18,356,928 | 2021 |
What was the outcome of reaction 'Drug hypersensitivity'? | Methimazole Desensitization in a 4-Year-Old With Refractory Graves Disease.
To describe a 4-year-old girl with Graves disease and methimazole allergy who underwent desensitization, allowing continued methimazole use when other treatments were contraindicated.
We formulated a desensitization plan utilizing cetirizine an... | Recovered | ReactionOutcome | CC BY-NC-ND | 34307852 | 18,356,928 | 2021 |
What was the outcome of reaction 'Myalgia'? | Methimazole Desensitization in a 4-Year-Old With Refractory Graves Disease.
To describe a 4-year-old girl with Graves disease and methimazole allergy who underwent desensitization, allowing continued methimazole use when other treatments were contraindicated.
We formulated a desensitization plan utilizing cetirizine an... | Recovered | ReactionOutcome | CC BY-NC-ND | 34307852 | 18,356,928 | 2021 |
What was the outcome of reaction 'Urticaria'? | Methimazole Desensitization in a 4-Year-Old With Refractory Graves Disease.
To describe a 4-year-old girl with Graves disease and methimazole allergy who underwent desensitization, allowing continued methimazole use when other treatments were contraindicated.
We formulated a desensitization plan utilizing cetirizine an... | Recovered | ReactionOutcome | CC BY-NC-ND | 34307852 | 18,356,928 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angle closure glaucoma'. | Multimodal etiology of drug induced angle closure with topical glaucoma therapy.
We present a case of acute onset of bilateral choroidal effusions leading to angle closure glaucoma attributed to multiple mechanism of actions causing ciliary body and aqueous flow disruption in the setting of topical glaucoma therapy wit... | BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE\BRINZOLAMIDE, HOMATROPINE HYDROBROMIDE, LATANOPROST | DrugsGivenReaction | CC BY-NC-ND | 34307961 | 19,607,945 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Choroidal effusion'. | Multimodal etiology of drug induced angle closure with topical glaucoma therapy.
We present a case of acute onset of bilateral choroidal effusions leading to angle closure glaucoma attributed to multiple mechanism of actions causing ciliary body and aqueous flow disruption in the setting of topical glaucoma therapy wit... | BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE\BRINZOLAMIDE, HOMATROPINE HYDROBROMIDE, LATANOPROST | DrugsGivenReaction | CC BY-NC-ND | 34307961 | 19,607,945 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Iridocyclitis'. | Multimodal etiology of drug induced angle closure with topical glaucoma therapy.
We present a case of acute onset of bilateral choroidal effusions leading to angle closure glaucoma attributed to multiple mechanism of actions causing ciliary body and aqueous flow disruption in the setting of topical glaucoma therapy wit... | BRIMONIDINE TARTRATE, BRIMONIDINE TARTRATE\BRINZOLAMIDE, HOMATROPINE HYDROBROMIDE, LATANOPROST | DrugsGivenReaction | CC BY-NC-ND | 34307961 | 19,607,945 | 2021-09 |
What was the dosage of drug 'BRIMONIDINE TARTRATE'? | Multimodal etiology of drug induced angle closure with topical glaucoma therapy.
We present a case of acute onset of bilateral choroidal effusions leading to angle closure glaucoma attributed to multiple mechanism of actions causing ciliary body and aqueous flow disruption in the setting of topical glaucoma therapy wit... | TID OU | DrugDosageText | CC BY-NC-ND | 34307961 | 19,607,945 | 2021-09 |
What was the dosage of drug 'BRIMONIDINE TARTRATE\BRINZOLAMIDE'? | Multimodal etiology of drug induced angle closure with topical glaucoma therapy.
We present a case of acute onset of bilateral choroidal effusions leading to angle closure glaucoma attributed to multiple mechanism of actions causing ciliary body and aqueous flow disruption in the setting of topical glaucoma therapy wit... | BID OU | DrugDosageText | CC BY-NC-ND | 34307961 | 19,607,945 | 2021-09 |
What was the dosage of drug 'HOMATROPINE HYDROBROMIDE'? | Multimodal etiology of drug induced angle closure with topical glaucoma therapy.
We present a case of acute onset of bilateral choroidal effusions leading to angle closure glaucoma attributed to multiple mechanism of actions causing ciliary body and aqueous flow disruption in the setting of topical glaucoma therapy wit... | TOPICAL HOMATROPINE BID OU | DrugDosageText | CC BY-NC-ND | 34307961 | 19,607,945 | 2021-09 |
What was the dosage of drug 'LATANOPROST'? | Multimodal etiology of drug induced angle closure with topical glaucoma therapy.
We present a case of acute onset of bilateral choroidal effusions leading to angle closure glaucoma attributed to multiple mechanism of actions causing ciliary body and aqueous flow disruption in the setting of topical glaucoma therapy wit... | QHS OU | DrugDosageText | CC BY-NC-ND | 34307961 | 19,607,945 | 2021-09 |
What was the outcome of reaction 'Angle closure glaucoma'? | Multimodal etiology of drug induced angle closure with topical glaucoma therapy.
We present a case of acute onset of bilateral choroidal effusions leading to angle closure glaucoma attributed to multiple mechanism of actions causing ciliary body and aqueous flow disruption in the setting of topical glaucoma therapy wit... | Recovered | ReactionOutcome | CC BY-NC-ND | 34307961 | 19,607,945 | 2021-09 |
What was the outcome of reaction 'Choroidal effusion'? | Multimodal etiology of drug induced angle closure with topical glaucoma therapy.
We present a case of acute onset of bilateral choroidal effusions leading to angle closure glaucoma attributed to multiple mechanism of actions causing ciliary body and aqueous flow disruption in the setting of topical glaucoma therapy wit... | Recovered | ReactionOutcome | CC BY-NC-ND | 34307961 | 19,607,945 | 2021-09 |
What was the outcome of reaction 'Iridocyclitis'? | Multimodal etiology of drug induced angle closure with topical glaucoma therapy.
We present a case of acute onset of bilateral choroidal effusions leading to angle closure glaucoma attributed to multiple mechanism of actions causing ciliary body and aqueous flow disruption in the setting of topical glaucoma therapy wit... | Recovered | ReactionOutcome | CC BY-NC-ND | 34307961 | 19,607,945 | 2021-09 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain'. | A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study.
Erythropoiesis-stimulating agents, standard of care for anemia of end-stage kidney disease, are associated with cardiovascular events. We evaluated the efficacy and safety of roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhi... | ERYTHROPOIETIN, IRON | DrugsGivenReaction | CC BY-NC-ND | 34307977 | 19,376,624 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute pulmonary oedema'. | A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study.
Erythropoiesis-stimulating agents, standard of care for anemia of end-stage kidney disease, are associated with cardiovascular events. We evaluated the efficacy and safety of roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhi... | ERYTHROPOIETIN, IRON | DrugsGivenReaction | CC BY-NC-ND | 34307977 | 19,376,624 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study.
Erythropoiesis-stimulating agents, standard of care for anemia of end-stage kidney disease, are associated with cardiovascular events. We evaluated the efficacy and safety of roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhi... | ERYTHROPOIETIN, IRON | DrugsGivenReaction | CC BY-NC-ND | 34307977 | 19,376,624 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angina pectoris'. | A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study.
Erythropoiesis-stimulating agents, standard of care for anemia of end-stage kidney disease, are associated with cardiovascular events. We evaluated the efficacy and safety of roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhi... | ERYTHROPOIETIN, IRON | DrugsGivenReaction | CC BY-NC-ND | 34307977 | 19,376,624 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Angina unstable'. | A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study.
Erythropoiesis-stimulating agents, standard of care for anemia of end-stage kidney disease, are associated with cardiovascular events. We evaluated the efficacy and safety of roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhi... | ERYTHROPOIETIN, IRON | DrugsGivenReaction | CC BY-NC-ND | 34307977 | 19,376,624 | 2021-07 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anxiety'. | A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study.
Erythropoiesis-stimulating agents, standard of care for anemia of end-stage kidney disease, are associated with cardiovascular events. We evaluated the efficacy and safety of roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhi... | ERYTHROPOIETIN, IRON | DrugsGivenReaction | CC BY-NC-ND | 34307977 | 19,376,624 | 2021-07 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.